Nerve Conduction Velocity Factors: Myelination,
and Disorders of Myelination
I.
Nerve Conduction Velocity Factors
A.
Fiber diameter
1. large fiber offers
less resistance through its core so adjacent regions are brought to threshold
faster (firing rate limiting factor = time to threshold)
2. Farther current
travels before charge diminishes, faster next segment will reach threshold
3. ability of action
potential to spread is proportional to amount of cytosol (smaller diameter =
more membrane per segment, less cytosol)
4. the closer to 1:1
(membrane to cytosol ratio), the faster is the conductance (due to resistance,
capacitance, and other properties)
B.
Degree of myelination
1. there are no
ion channels beneath the myelin--no passive (leak) channels and no active
(gated) channels at internode regions
2. there
ARE channels at the nodes (leads to the appearance of saltatory conduction)
3. myelin increases
resistance so charge less likely to spread in outward direction
4.
this has the effect of increasing the conduction velocity up to 100-fold.
II. Because nerve fibers have different properties as a result of their conduction velocities, diameters, and other characteristics, they can be divided into three categories. A, B, and C (although some
sensory physiologists use Roman Numerals for the
sensory fibers in the dorsal roots of spinal nerves).
III.
Disorders of Myelination
A. May involve white matter of the CNS or the PNS
1. myelin is heavily proteinated and these proteins may be attacked by the immune system for various reasons or may be defective because of faulty genetic coding
(i.e., mutations)
2.
MS is considered a disorder of the CNS
3. Guillain-Barre
Syndrome (GBS) is considered a disorder of the PNS
B. May be Demyelinating (e.g.,
MS) or dysmyelinating (Charcot-Marie-Tooth)
C.
May be acquired or inherited
1. Charcot-Marie-Tooth
is inherited
2. GBS is considered
acquired (triggering event unknown, but probably due to presence of another
pathogen, possibly viral)
D.
Other causes of acquired demyelination
1.
radiation
2.
infarct
3.
tumors
4.
toxins or drugs
5.
infections
IV.
Select Disorders
A.
MS
1. etiology: usually
autoimmune demyelinating disorder
a. hypothetical causes:
geographical (climate, seasonal changes), viral (direct or indirect), genetic
(no gene located, concordance rate: 30%)
2. mechanism:
§
Patches
of inflammation occur in CNS
§
Inflammation
results in edema
§
Inflammation
and edema produce destruction of myelin
§
Glial
cells begin remyelination
§
Remyelination
may be insufficient or can produce scarring if repetitive
§
Demyelinated
neuron is prone to axonal injury as well as disruption of AP transmission
§
Axonal
injury can lead to degeneration of neuron, which will not be repaired
3.
Forms of MS
a.
relapsing-remitting—most common (~60%)
b.
primary progressive
c.
secondary progressive
d.
benign
4.
Symptoms:
§
Optic
neuritis
§
Muscle
weakness in limbs
§
Paresthesias
§
Bladder
and bowel function disruption
§
Sexual
difficulty
§
Fatigue
§
Cognitive-affective
(depends on location of sclera, depression is common)
5.
Diagnostic tools: MRI, lumbar puncture, evoked potentials
6.
Treatment
a.
treatment of course of disease: interferons
b.
treatment of exacerbations: corticodsteroids
c. treatment of
symptoms: controlling environment (e.g., maintaining cool temps, cautious
exercise, antispastic meds, external treatment of bladder and bowel problems or
catheterization for bladder problems, counseling—family and patient)
B.
Guillain-Barre Syndrome
1.
Etiology
a. typically follows a
bacterial or viral infections (e.g., respiratory or GI)
b. autoimmune disorder
in which an attack is mounted against PNS
c. possibly the immune
system is confused by viral or bacterial antigens that are similar to proteins
of the PNS
2.
Forms (types)
a.
axonal (acute motor-sensory-axonal neuropathy)
b.
demyelinating
3.
Symptoms
a.
quick to appear, slower to disappear
b.
initially weakness, progressing to full paralysis
c. peak paralysis occurs
within 2-3 weeks of initial symptoms
4.
Diagnosis
a.
symptoms that fit the clinical picture
b.
lumbar puncture
c.
NCV
5.
Treatment
a.
plasmaphoresis
b.
immunoglobulin therapy
c. maintaining cardiac
and respiratory function (most important)
C.
Leukodystrophies
1. Overview
a. CNS vs PNS
b. examples
Some
Differences Among De- and Dysmyelinating Disorders
|
CNS:
White matter |
PNS:
Neuropathies |
|
Demyelinating: primarily acquired. MS, Progressive Multifocal Leukoencephalopahty (PML), Encephalomyelitis, Central Pontine Myelolysis (CPM), Anti-MAG Disease |
Acquired: primarily autoimmune, demyelinating polyneuropathies. Acute: Guillain-Barre Syndrome (GBS) Chronic: Chronic Immune Demyelinating Polyneuropathy (CIDP), Anti-MAG Syndrome, Multiple Motor Neuropathy (MMN) |
|
Dysmyelinating: Primarily inheritied Leukodystrophies: Adrenoleukodystrophy (ALD), Alexander’s Disease, Canavan Disease, Krabbe Disease, Metachromatic Leukodystrophy (MLD), Pelizaeu-Merzbacher Disease, Refsum Disease, Cockayne Syndrome, Van der Knapp Syndrome, Zellweger Syndrome |
Hereditary: primarily dysmyelinating. Hereditary Motor Sensory Neuropathies (HMSN), Charcot-Marie-Tooth (CMT), Cockayne Syndrome, Krabbe Disease, Metachromatic Leukodystrophy (MLD), Refsum Disease, Pelizaeus-Merzbacher Disease |
|
Other causes of acquired demyelination in the CNS or PNS: radiation, infarct, tumors, toxins, drugs, infection |
|